Pharmaceutical sector calls for reversal of move hitting imports
News | 15 August 2012
The Chamber of the Pharmaceutical Industry (Cifar) requested the Executive Power to "keep" pharmaceutical products in list 1 of the Foreign Exchange Administration Commission (Cadivi), to revert a resolution published last week. "It is very important ...
Click on the link to read the full article at El Universal
(This link will open in a new window)
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
